Organ regeneration method utilizing blastocyst complementation

US2020008404A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2020008404-A1
Application numberUS-201916356570-A
CountryUS
Kind codeA1
Filing dateMar 18, 2019
Priority dateFeb 22, 2007
Publication dateJan 9, 2020
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An object of the present invention is to produce a mammalian organ having a complicated cellular composition composed of multiple kinds of cells, such as kidney, pancreas, thymus and hair, in the living body of a non-human animal. The inventors of the present invention applied the chimeric animal assay described above, to a novel solid organ production method. More specifically, the inventors has shown that a model mouse which is deficient of kidney, pancreas, thymus or hair due to the dysfunction of the metanephric mesenchyme that is differentiated into most of an adult kidney, is rescued by blastocyst complementation by the chimeric animal assay, and whereby a kidney, a pancreas, thymus or hair can be newly produced.

First claim

Opening claim text (preview).

1 . A method for producing a target organ in the living body of a non-human mammal having an abnormality associated with a lack of development of the target organ in the development stage, the target organ being derived from an allogeneic and/or xenogeneic mammal that is an individual different from the non-human mammal, the method comprising: a) preparing a cell derived from the allogeneic and/or xenogeneic mammal; b) transplanting the cell into a blastocyst stage fertilized egg of the non-human mammal; c) developing the fertilized egg in the womb of a non-human surrogate parent mammal to obtain a litter; and d) obtaining the target organ from an individual of the litter. 2 . The method according to claim 1 , wherein said cell is an embryonic stem cell (ES cell) or an induced pluripotent stem cell (iPS cell). 3 . The method according to claim 1 , wherein said cell is derived from a mouse. 4 . The method according to claim 1 , wherein said organ to be produced is selected from a kidney, a pancreas, thymus and hair. 5 . The method according to claim 1 , wherein said non-human mammal is a mouse. 6 . The method according to claim 1 , wherein said mouse is a Sall1 knockout mouse, a Pdx-1 knockout mouse, or a nude mouse. 7 . The method according to claim 1 , wherein said target organ is completely derived from said allogeneic and/or xenogeneic mammal. 8 . The method according to claim 1 , wherein said cell is derived from a rat. 9 . The method according to claim 1 , wherein said cell and said non-human mammal are heterologous to each other. 10 . The method according to claim 1 , wherein said cell is from a rat, and said non-human mammal is from a mouse. 11 . A non-human mammal having an abnormality associated with a lack of development of a target organ in the development stage, produced according to a method comprising: a) preparing a cell derived from an allogeneic and/or xenogeneic mammal that is an individual different from the non-human mammal; b) transplanting the cell into a blastocyst stage fertilized egg of the non-human mammal; and c) developing the fertilized egg in the womb of a non-human surrogate parent mammal to obtain a litter. 12 . (canceled) 13 . A set for producing a target organ, the set comprising: A) a non-human mammal having an abnormality associated with a lack of the target organ development in the development stage; and B) a cell derived from an allogeneic and/or xenogeneic mammal of the same species as the non-human mammal. 14 . The set according to claim 13 , wherein said cell and said non-human mammal are heterologous to each other. 15 . The method according to claim 1 , wherein said cell is from a rat, and said non-human mammal is from a mouse.

Assignees

Inventors

Classifications

  • Animals treated with compounds which are neither proteins nor nucleic acids · CPC title

  • Chimeric vertebrates, e.g. comprising exogenous cells · CPC title

  • Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2020008404A1 cover?
An object of the present invention is to produce a mammalian organ having a complicated cellular composition composed of multiple kinds of cells, such as kidney, pancreas, thymus and hair, in the living body of a non-human animal. The inventors of the present invention applied the chimeric animal assay described above, to a novel solid organ production method. More specifically, the inventors h…
Who is the assignee on this patent?
Univ Tokyo
What technology area does this patent fall under?
Primary CPC classification A01K67/0271. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jan 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).